Eli Lilly manufactures Wegovy (semaglutide 2.4 mg), an FDA-approved prescription medicine for chronic weight management in adults with obesity or overweight with at least one weight-related condition. This overview explains how Wegovy is typically accessed, what to expect from eligibility and pricing, and how savings programs and insurance coverage can affect cost. It is designed as an enduring, fact-focused resource for understanding the relationship between Eli Lilly and Wegovy, treatment steps, and long-term use considerations.
What Wegovy Is and How It Works
Wegovy is a GLP-1 receptor agonist that mimics a hormone involved in appetite regulation and glucose control. It is administered as a once-weekly subcutaneous injection and is approved for adults with obesity (BMI of 30 or higher) or adults with overweight (BMI of 27 or higher) who also have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or dyslipidemia. The drug supports weight loss when combined with reduced-calorie diet and increased physical activity. It is not a standalone solution but a tool to help sustain calorie-controlled habits. Results vary, and treatment is generally intended for long-term use under medical supervision.
How to Get Wegovy from Eli Lilly
Eli Lilly does not sell Wegovy directly to consumers; instead, prescriptions are filled at pharmacies, which obtain the medicine from Lilly or its distribution partners. To start treatment, you need a valid prescription from a licensed healthcare provider who can assess whether Wegovy is appropriate for your health profile. After a prescription is written, a pharmacy can dispense the medication and provide guidance on storage, injection technique, and schedule. People without prescription coverage may pay higher prices, highlighting the importance of exploring savings options and discount programs offered by Eli Lilly and third parties.
Pricing, Savings, and Insurance Considerations
Cost is a major factor for many people considering or continuing Wegovy. Prices at retail pharmacies can be high without insurance, but most commercial plans and some Medicare Part D plans cover it when medically necessary, often with a copay or coinsurance. Eli Lilly provides a savings card program for eligible patients with commercial insurance, which may lower out-of-pocket costs to a set copay. Uninsured or underinsured patients may qualify for Lilly patient assistance, which can provide the medication at a reduced price or for free based on income and other criteria. Prices and program rules change, so verifying current offers and eligibility with Lilly and your pharmacist is essential.
Price Overview and Typical Factors
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Manufacturer | Eli Lilly and Company | Public company disclosure and product labeling |
| Active Ingredient | Semaglutide 2.4 mg | FDA-approved drug label |
| Administration | Once-weekly subcutaneous injection | Prescribing information |
| Typical cash price range | Several hundred to over a thousand USD per month without insurance | Published pharmacy pricing data and patient assistance documentation |
| Savings programs | Eli Lilly co-pay card and patient assistance for eligible individuals | Eli Lilly patient support terms and conditions |
| Insurance variability | Coverage and cost-sharing depend on plan type and medical necessity | Plan evidence of coverage and pharmacy benefit terms |
Eligibility, Medical Evaluation, and Next Steps
Wegovy is not suitable for everyone. A healthcare provider will review your medical history, current medications, and weight status to determine eligibility. Criteria include having a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition, and not having personal or family histories that contraindicate GLP-1 receptor agonist use. Certain medications and health issues may require adjustments or closer monitoring. If you are a candidate, your provider will set a plan that includes dosing, monitoring, and follow-up labs. Regular check-ins help manage side effects, adjust treatment, and track progress toward goals.
Potential Side Effects and Safety Considerations
Common side effects of Wegovy include nausea, vomiting, diarrhea, constipation, and abdominal pain, especially when treatment is started or doses are increased. These symptoms often decrease over time as your body adjusts. Serious risks include possible thyroid C-cell tumors observed in animal studies, pancreatitis, gallbladder problems, and kidney issues in people with preexisting conditions. Hypoglycemia can occur, particularly if Wegovy is used with other glucose-lowering medications. Allergic reactions and injection-site reactions are also possible. Tell your provider about all medications and supplements you take, and seek immediate medical attention for severe or persistent symptoms.
Lifestyle Support and Long-Term Use
Wegovy works best when paired with sustained lifestyle changes, including a reduced-calorie, balanced diet and regular physical activity. Behavioral support, whether through counseling, group programs, or digital tools, can improve results and help maintain new habits. Because obesity and overweight are chronic conditions, long-term or indefinite treatment may be needed to sustain weight loss. Stopping Wegovy often leads to weight regain, so ongoing medical follow-up is important. Your healthcare team can help create a sustainable plan that integrates medication, nutrition, movement, and mental health support.
Insurance, Prior Authorization, and Practical Access
Navigating insurance can affect how quickly and affordably you start Wegovy. Many plans require prior authorization, meaning your provider must submit clinical information justifying medical necessity. Working closely with your clinician and insurer can reduce delays. If a claim is denied, options include appealing the decision, requesting a waiver, or exploring Eli Lilly savings programs and patient advocacy resources. Pharmacy benefit managers and formularies also influence which medications are covered and at what cost. Confirming coverage details before filling a prescription can prevent surprises and help you choose the most affordable path.
Key Facts at a Glance
- Eli Lilly manufactures Wegovy; it is not sold over the counter or directly to consumers.
- A prescription from a licensed clinician is required to obtain Wegovy at a pharmacy.
- Insurance coverage and Lilly savings programs can significantly lower out-of-pocket costs.
- Eligibility depends on BMI, weight-related health conditions, and medical history.
- Common side effects include gastrointestinal symptoms, which often improve over time.
- Long-term lifestyle changes enhance weight loss outcomes and maintenance.
- Prior authorization and plan details can affect access and affordability.
How to Learn More and Take Action
To determine if Wegovy is right for you, schedule an appointment with a qualified healthcare provider for a personalized assessment. Bring a list of your medications, health conditions, and questions about costs and coverage. Ask your pharmacist about storage, injection technique, and local resources for support. You can also review official resources from Eli Lilly for current savings and assistance programs. Consistent follow-up with your care team helps ensure safe, effective, and affordable treatment over time.